JAZZ vs PACK · P/E 1988, rev $4.07B vs rev $368.9M
Jazz Pharmaceuticals PLC (JAZZ) versus Ranpak Holdings Corp (PACK) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Ranpak Holdings Corp (PACK) is a packaging & containers company listed on NYSE.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported PACK revenue for 2024-12-31 was $368.9M. Net income was -$21.5M. Revenue was up 9.7% from 2023-12-31 to 2024-12-31. PACK currently screens at market cap $617.6M.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. PACK currently screens at market cap $617.6M.
Not investment advice. Open the JAZZ and PACK stock pages for the full models.
Not investment advice.